Side-by-side comparison of AI visibility scores, market position, and capabilities
Mental health care clinic network with in-network insurance coverage, San Francisco CA, raised $52M+. Hybrid virtual and in-person therapy with major payer contracts.
Octave is a San Francisco, California-based mental health company founded in 2018 that operates a network of mental health clinics offering therapy and psychiatric care with in-network insurance coverage from major carriers. The company has raised over $52 million and has built a hybrid model offering both in-person care at physical clinic locations and virtual therapy, enabling clients to choose the modality that works best for their needs and circumstances.\n\nOctave's business model prioritizes in-network insurance access, negotiating directly with major commercial payers including Blue Cross Blue Shield, Aetna, and Cigna to make therapy financially accessible to patients who have historically faced high out-of-pocket costs or been directed to out-of-network providers. The company handles credentialing, insurance billing, and administrative infrastructure centrally, allowing its therapists and psychiatrists to focus on clinical work rather than paperwork.\n\nThe company has expanded to multiple markets in California and New York, with plans to grow its geographic footprint. Octave serves adults with a range of mental health conditions including anxiety, depression, relationship difficulties, trauma, and life transitions. By offering in-person clinic access alongside telehealth, Octave differentiates from purely virtual mental health platforms and appeals to clients who prefer or require face-to-face care. Octave is part of the emerging category of tech-enabled mental health clinic operators alongside Mindpath Health and Two Chairs.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.